European Heart Journal, 41(36), 3402-3418. Oxford University Press European Heart Journal Serenelli, M, Böhm, M, Inzucchi, S E, Køber, L, Kosiborod, M N, Martinez, F A, Ponikowski, P, Sabatine, M S, Solomon, S D, DeMets, D L, Bengtsson, O, Sjöstrand, M, Langkilde, A M, Anand, I S, Chiang, C E, Chopra, V K, de Boer, R A, Diez, M, Dukát, A, Ge, J, Howlett, J G, Katova, T, Kitakaze, M, Ljungman, C E A, Verma, S, Docherty, K F, Jhund, P S & McMurray, J J V 2020, ' Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF) ', European Heart Journal, vol. 41, no. 36, pp. 3402-3418 . https://doi.org/10.1093/eurheartj/ehaa496
European Heart Journal Docherty, K F, Jhund, P S, Inzucchi, S E, Køber, L, Kosiborod, M N, Martinez, F A, Ponikowski, P, Demets, D L, Sabatine, M S, Bengtsson, O, Sjöstrand, M, Langkilde, A M, Desai, A S, Diez, M, Howlett, J G, Katova, T, Ljungman, C E A, O'Meara, E, Petrie, M C, Schou, M, Verma, S, Vinh, P N, Solomon, S D & McMurray, J J V 2020, ' Effects of dapagliflozin in DAPA-HF according to background heart failure therapy ', European Heart Journal, vol. 41, no. 25, pp. 2379-2392 . https://doi.org/10.1093/eurheartj/ehaa183
Dipòsit Digital de la UB Universidad de Barcelona Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual) Universidade de São Paulo (USP) instacron:USP New England Journal of Medicine, 381(17), 1609-1620. MASSACHUSETTS MEDICAL SOC